CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission: First Clinical Trial Results
In a clinical trial published in Nature Medicine, researchers at Charité—Universitätsmedizin Berlin treated six patients suffering from severe, treatment-refractory rheumatoid arthritis using mivocabtagene autoleucel (miv-cel), an autologous CD19 CAR T-cell ... Read More